Position history for BlackRock, Inc.'s holdings in HALOZYME THERAPEUTICS INC
BlackRock, Inc. holds 13.3M shares of HALO (HALOZYME THERAPEUTICS INC), worth $857.3M as of 2026-Q1. The position was increased (+0.8% shares). HALO represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$857.3M
Current Shares
13.3M
Total Value Change
+$17.5M
Total Shares Change
-4.3M
Other major holders of HALO: BlackRock Finance, Inc., VANGUARD GROUP INC
Increased |
| 13.3M |
+0.8% |
| $857.3M |
| 0.0% |
| $69.40 |
32 |
| 2025-Q4 | Increased | 13.2M | +2.3% | $885.3M | 0.0% | $67.70 | 33 |
| 2025-Q3 | Decreased | 12.9M | -2.6% | $943.2M | 0.0% | $73.29 | 0 |
| 2025-Q2 | Decreased | 13.2M | -22.8% | $686.7M | 0.0% | $52.21 | 0 |
| 2025-Q1 | Decreased | 17.1M | -2.7% | $1.1B | 0.0% | $63.84 | 0 |
| 2024-Q4 | New | 17.6M | - | $839.8M | 0.0% | $47.99 | 44 |